Infusion of neutrophil precursors for treatment of neutropenia

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 9371, 435325, C12N 500

Patent

active

058465294

ABSTRACT:
The invention provides a method of treating a patient having a reduced population of neutrophils following a myeloablative cancer treatment such as high dose chemotherapy. Following myeloablative therapy, a cell composition of at least 25% neutrophil precursors, i.e. promyelocytes, myelocytes, and metamyelocytes, is administered to the patient. Thereafter, the neutrophil precursors differentiate rapidly in vivo to replenish the supply of mature neutrophils for fighting infection. The method is used to reduce the neutropenic window between the time of myeloablative therapy and the time required for infused stem cells to proliferate and differentiate into mature neutrophils.

REFERENCES:
patent: 4786599 (1988-11-01), Chessebeuf et al.
patent: 4816401 (1989-03-01), Taupier et al.
patent: 5004681 (1991-04-01), Boyse et al.
patent: 5045467 (1991-09-01), Bertheussen
patent: 5063157 (1991-11-01), Stockinger
patent: 5135866 (1992-08-01), Herfetz et al.
patent: 5155036 (1992-10-01), Hagiwara et al.
patent: 5199942 (1993-04-01), Gillis
patent: 5232848 (1993-08-01), Wolfe et al.
patent: 5541103 (1996-07-01), Kanz et al.
ATCC "Hybridomas" in: Catalogue of Cell Lines & Hybridomas, 7th ed., pp. 320, 348, 374, 421 (1992).
ATCC Catalogue of Cell Lines and Hybridomas, 6th ed., pp. 342-355 (1988).
Bjare, Pharma. Ther. 53:355-374 (1992).
Bruno et al., "Effect of Interleukin 6 and Interleukin 1 on in vitro Human Megakaryocytopoiesis: Its Interaction with Other Cytokines," Exp. Hematol. 17:1038-1043 (1989).
Burrow et al., Proc. Natl. Acad. Sci. 90:6066-6070 (1993).
Da et al., Brit. J. Haematol. 78:42-47 (1991).
Dexter et al., J Cell Physiol 91:335 (1977).
Douay et al., Exp. Hematol. 14:358-365 (1986).
Drouet et al., J. of Haemotol. 73 (2):143-147 (1989).
Egeland et al.,"Myeloid Differentiation of Purified CD34.sup.+ Cells After Stimulation With Recombinant Human Granulocyte-Monocyte Colony-Stimulating Factor (CSF), Granulocyte-CSF, Monocyte-CSF, and Interleukin-3", Blood, 78 (12):3192-3199 (1991).
Hardwick et al., J. Hematother. 1:379-386 (1992).
Hayrock, Blood 80 (6), pp. 1406-1412 (1992).
Jakoby et al. (eds.), Meth. in Enzymology LVIII (Cell Culture): 44-109 (1979).
Jandl, Blood, Textbook of Hematology 441-480 (1987).
Koike et al., "Interleukin-6 Enhances Murine Megakaryocytopoiesis in Serum-Free Culture," Blood 75 (12):2286-2291 (1990).
Koller et al., Bio/Tech. 11:358-363.
Kubota et al., "Murine Granulocyte/Macrophage and Megacaryocyte Colony Formation in Serum-Free Cultures," Biol. Abs. 82 (1986).
Lansdorp et al., J. Exp. Med. 175:1501-1509 (1991).
Long, Stem Cells 11:33-44 (1993).
Marmont et al., Atlas of Blood Cells, Function and Pathology in "Neutrophils" pp. 159-190.
Merchav et al., Intl. J. Cell Cloning 2:356-367 (1984).
Metcalf et al., Proc. Natl. Acad. Sci. 72:1744 (1975).
Nakef et al., Ser Heamat 8:4 (1975).
Okano et al. ACTA Haemotol. (JPN) 53:1213-1221 (1990).
Paulus, "Platelet kinetics" in: Williams et al. (eds.) Hematol. 1251-1260 (1990).
Ponting et al., Growth Factors 4:165-713 (1991).
Smith et al., Exp. Hematol. 21:870-877 (1993).
Somerville et al., "Future Directions in Transplantation: Xenotransplantation," Kidney Intl. 44 (suppl 42): S-112-S-121 (1993).
Spitzer et al., Blood 55:317-323.
Spooncer et al., Differentiation 31:111-118 (1986).
Teramura et al., "Clonal Growth of Human Megakaryocyte Progenitors in Serum-Free Cultures: Effect of Recombinant Human Interleukin 3" Exp. Hematol. 16:843-848 (1988).
Vincent et al., Exp. Hematol. 20 (1):17-23 (1992).
Warren et al., "The Role of Interleukin 6 and Interleukin 1 in Megakaryocyte Development," Exp. Hematol. 17 (11), pp. 1095-1099 (1989).
Wu et al., Pathol. 22:145-148 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Infusion of neutrophil precursors for treatment of neutropenia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Infusion of neutrophil precursors for treatment of neutropenia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Infusion of neutrophil precursors for treatment of neutropenia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-174495

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.